2Tsuji BT,Rybak MJ,Cheung CM,et al.Communityand health care-associated methicillin-resistant Staphylococcus aureus:a comparison of molecular epidemiology and antimicrobial activitiesof various agents[J].Diagn Microbiol Infect Dis,2007,58(1):41-47.
3Gould FK,Brindle R,Chadwick PR,et al.Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK[J].J Antimicrob Chemother,2009,63 (5):849-861.
4Schmitz GR,Bruner D,Pitotti R,et al.Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillinresistant Staphylococcus aureus infection[J].Ann Emerg Med,2010,56(3):283-287.
5Duong M,Markwell S,Peter J,et al.Randomized,controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient[J].Ann Emerg Med,2009,55 (5):401-407.
6Tong SY,Andrews RM,Kearns T,et al.Trimethopim-sulfamethoxazole compared with benzathine penicillin for treatment of impetigo in Aboriginal children:a pilot randomised controlled trial[J].J Paediatr Child Health,2010,46(3):131-133.
7Markowitz N,Quinn EL,Saravolatz LD.Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection[J].Ann Intern Med,1992,117 (5):390-398.
